Clinical utility of the pan-immune-inflammation value in breast cancer patients

Overview of attention for article published in Frontiers in oncology, August 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 8,962 followers.

RT @BreastCaConnect: 📊⏳ Pan-immune-inflammation value (PIV) emerges as a potential prognostic #biomarker for #BC❗️ A meta-analysis of 295…

17 Sep 2023

Reply Repost Favourite

📊⏳ Pan-immune-inflammation value (PIV) emerges as a potential prognostic #biomarker for #BC❗️ A meta-analysis of 2953 patients reveals higher #PIV links to shorter #OS and #PFS. More details in the article: https://t.co/ELn3TIe0DA #MedEd #bcsm

17 Sep 2023

Reply Repost Favourite

Clinical utility of the pan-immune-inflammation value in breast cancer patients https://t.co/atBRLREmRs

15 Sep 2023

Reply Repost Favourite

New research: Clinical utility of the pan-immune-inflammation value in breast cancer patients: Background The newly discovered pan-immune-inflammation value (PIV) has been illustrated to have good prognostic value for cancer patient prognosis.… #oncology

06 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.